Pinnacle Associates LTD Intra Cellular Therapies, Inc. Transaction History

Pinnacle Associates LTD

  • $6.3 Billion
  • Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Pinnacle Associates LTD holds 176,124 shares of ITCI stock, worth $14.7 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
176,124
Previous 171,069 2.95%
Holding current value
$14.7 Million
Previous $11.7 Million 9.92%
% of portfolio
0.2%
Previous 0.19%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
BUY
$67.99 - $80.84 $343,689 - $408,646
5,055 Added 2.95%
176,124 $12.9 Million
Q2 2024

Jul 30, 2024
SELL
$64.76 - $79.84 $182,817 - $225,388
-2,823 Reduced 1.62%
171,069 $11.7 Million
Q1 2024

Apr 26, 2024
SELL
$64.37 - $75.65 $143,673 - $168,850
-2,232 Reduced 1.27%
173,892 $12 Million
Q4 2023

Jan 19, 2024
SELL
$46.37 - $73.65 $50,728 - $80,573
-1,094 Reduced 0.62%
176,124 $12.6 Million
Q3 2023

Oct 23, 2023
SELL
$52.09 - $64.1 $401,249 - $493,762
-7,703 Reduced 4.17%
177,218 $9.23 Million
Q2 2023

Jul 26, 2023
SELL
$54.67 - $66.44 $381,705 - $463,884
-6,982 Reduced 3.64%
184,921 $11.7 Million
Q1 2023

May 04, 2023
SELL
$43.8 - $56.99 $138,145 - $179,746
-3,154 Reduced 1.62%
191,903 $10.4 Million
Q4 2022

Jan 31, 2023
BUY
$44.07 - $54.45 $27,323 - $33,759
620 Added 0.32%
195,057 $10.3 Million
Q4 2022

Jan 25, 2023
SELL
$44.07 - $54.45 $176,500 - $218,072
-4,005 Reduced 2.02%
194,437 $0
Q3 2022

Oct 31, 2022
SELL
$42.7 - $59.99 $323,794 - $454,904
-7,583 Reduced 3.68%
198,442 $9.23 Million
Q2 2022

Aug 02, 2022
SELL
$43.0 - $65.64 $21,887 - $33,410
-509 Reduced 0.25%
206,025 $11.8 Million
Q1 2022

May 05, 2022
SELL
$38.74 - $62.09 $386,896 - $620,092
-9,987 Reduced 4.61%
206,534 $12.6 Million
Q4 2021

Feb 02, 2022
SELL
$35.2 - $53.42 $48,118 - $73,025
-1,367 Reduced 0.63%
216,521 $11.3 Million
Q3 2021

Oct 19, 2021
SELL
$28.72 - $42.49 $218,559 - $323,348
-7,610 Reduced 3.37%
217,888 $8.12 Million
Q2 2021

Aug 02, 2021
BUY
$29.3 - $44.5 $82,889 - $125,890
2,829 Added 1.27%
225,498 $9.21 Million
Q1 2021

May 12, 2021
SELL
$30.8 - $39.51 $755,370 - $968,982
-24,525 Reduced 9.92%
222,669 $7.56 Million
Q4 2020

Jan 26, 2021
SELL
$23.34 - $32.22 $396,453 - $547,288
-16,986 Reduced 6.43%
247,194 $7.86 Million
Q3 2020

Oct 23, 2020
SELL
$17.61 - $31.86 $204,187 - $369,416
-11,595 Reduced 4.2%
264,180 $6.78 Million
Q2 2020

Aug 14, 2020
BUY
$14.35 - $26.64 $3.96 Million - $7.35 Million
275,775 New
275,775 $7.08 Million

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.87B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Pinnacle Associates LTD Portfolio

Follow Pinnacle Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email